Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–5 of 5 results
Advanced filters: Author: "X. Yu" Clear advanced filters

  • As the COVID-19 pandemic rages globally, interest in antiviral treatments has never been higher. Antibodies are key defence components, and engineering them to better exploit their natural functions might boost therapeutic options.

    • Xiaojie Yu
    • Mark S. Cragg
    News & Views
    Nature
    Volume: 588, P: 398-399

  • Stroke has a heavy socioeconomic burden. A subset of patients with transient or nondisabling cerebral ischaemic events will experience recurrent stroke, leading to permanent deficits. Two new studies tackle the challenge of identifying the patients most at risk for recurrent stroke via examination of radiological and serum biomarkers.

    • Amy Y. X. Yu
    • Shelagh B. Coutts
    News & Views
    Nature Reviews Neurology
    Volume: 11, P: 131-133

  • Yu et al examined a panel of both experimental and clinically-relevant TNF agonists in order to advance our understanding of the mechanisms underlying their varying activities and anti-tumor responses. They demonstrated that agonists with greater activity induced higher density receptor clustering and specific super-structures as opposed to simply larger receptor clusters.

    • Xiaojie Yu
    • Sonya James
    • Mark S. Cragg
    ResearchOpen Access
    Communications Biology
    Volume: 4, P: 1-15